Stockpolly
Search
DWTX · NASDAQ · Biotechnology

Dogwood Therapeutics (DWTX)

Develops non-opioid therapies for chemotherapy-related neuropathic pain.

$2.47
Pre-market−0.01 (−0.40%)
At close$2.48(−5.70%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue000000000000
Gross profit000000000000
1111284416455
Research & development0000122315233
111125211122
Selling & marketing000000000000
General & administrative111125211122
Operating income−1−1−1−1−2−8−4−4−16−4−5−5
000000−60000−9
Interest income000000000000
Interest expense000000000000
Other non-operating income000000600000
Income before tax−1−1−1−1−2−8−11−4−16−4−5−14
Income tax expense00000000000−2
Net income from continuing operations−1−1−1−1−2−8−11−4−16−4−5−12
Other adjustments000000000000
Net income−1−1−1−1−2−8−11−4−16−4−5−12
EPS, basic−$1.62−$1.43−$1.68−$1.15−$2.05−$5.90−$8.45−$1.99−$8.20−$0.26−$0.15−$0.34
EPS, diluted−$1.62−$1.43−$1.68−$1.15−$2.05−$5.90−$8.45−$1.99−$8.20−$0.26−$0.15−$0.34
Weighted average shares, basic111111112153434
Weighted average shares, diluted111111112153434
EBITDA−1−1−1−1−2−8−11−4−16−4−5−5
Depreciation & amortization000000000000
EBIT−1−1−1−1−2−8−11−4−16−4−5−5